JAKARTA - Indonesia has officially become one of the countries where the M72 Tubercolosis vaccine clinic (TBC) was tested by Bill Gates. Apart from Indonesia, there are several other countries that are also testing the vaccine.

These countries are South Africa, Kenya, Zambia, and Malawi. Quoted from the website of the Indonesian Ministry of Health, on Friday, May 9, 2025, the total participants in the phase 3 clinical trial totaled 20,081 people from five countries.

South Africa became the biggest contributor with 13,071 participants, then Kenya with 3,579 participants, Zambia with 889 participants, and Malawi with 447 participants.

Indonesia itself has completed the recruitment of participants for the phase 3 clinical testing of the vaccine, with a total of 2,095 participants from the age group of teenagers and adults.

In Indonesia, this review activity is carried out in various leading medical institutions. Starting from the Friendship Hospital, the Cempaka Putih Islamic Hospital Jakarta, the University of Indonesia Hospital (RSUI), the Padjadjaran Faculty of Medicine (FK UNPAD), and the Faculty of Medicine, University of Indonesia (FKUI).

"The implementation of clinical trials begins on September 3, 2024, and the official recruitment of participants has been completed as of April 16, 2025," said Head of the Indonesian Ministry of Health's Public Communication and Information Bureau, Aji Muhawarman.

Indonesia's involvement in this test is referred to as the state's commitment to eradicating TB. All testing implementations in Indonesia are also closely monitored by the World Health Organization (WHO), BPOM, the Indonesian Ministry of Health, as well as national and international TB vaccine experts.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)